Optimized Gemcitabine Therapy in Combination with E7 Peptide Immunization Elicits Tumor Cure by Preventing Ag-Specific CTL Inhibition in Animals with Large Established Tumors. [electronic resource]
Producer: 20181009Description: 850-860 p. digitalISSN:- 1557-7430
- Adenocarcinoma -- genetics
- Animals
- Antibodies -- pharmacology
- Antigens, Neoplasm -- administration & dosage
- Antimetabolites, Antineoplastic -- pharmacology
- Cancer Vaccines -- administration & dosage
- Cell Line, Tumor
- Combined Modality Therapy -- methods
- Cytotoxicity, Immunologic -- drug effects
- Deoxycytidine -- analogs & derivatives
- Drug Therapy -- methods
- Epithelial Cells -- drug effects
- Female
- Humans
- Immunization
- Immunotherapy -- methods
- Mice
- Mice, Inbred C57BL
- Neoplasm Transplantation
- Oligodeoxyribonucleotides -- administration & dosage
- Peptides -- administration & dosage
- T-Lymphocytes, Cytotoxic -- drug effects
- Tumor Burden -- drug effects
- Tumor Necrosis Factor Receptor Superfamily, Member 9 -- antagonists & inhibitors
- Gemcitabine
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.